For research use only. Not for therapeutic Use.
Gimeracil (Gimestat)(CAT: I000224) is a potent inhibitor of dihydropyrimidine dehydrogenase (DPYD), the enzyme responsible for the degradation of pyrimidines, including the chemotherapeutic agent 5-fluorouracil (5-FU). By inhibiting DPYD, Gimeracil increases the systemic availability and efficacy of 5-FU, enhancing its anticancer effects. Additionally, Gimeracil has been shown to inhibit homologous recombination, a critical DNA repair mechanism, which further sensitizes cancer cells to DNA-damaging therapies. This dual mechanism makes it a valuable compound in oncology research, particularly for exploring combination therapies aimed at improving the efficacy of pyrimidine-based treatments and targeting DNA repair pathways in cancer cells.
Catalog Number | I000224 |
CAS Number | 103766-25-2 |
Synonyms | 5-chloro-4-hydroxy-1H-pyridin-2-one |
Molecular Formula | C5H4ClNO2 |
Purity | ≥95% |
Target | Dehydrogenase |
Solubility | DMSO 29 mg/ml |
Storage | 3 years -20C powder |
IUPAC Name | 5-chloro-4-hydroxy-1H-pyridin-2-one |
InChI | InChI=1S/C5H4ClNO2/c6-3-2-7-5(9)1-4(3)8/h1-2H,(H2,7,8,9) |
InChIKey | ZPLQIPFOCGIIHV-UHFFFAOYSA-N |
SMILES | C1=C(C(=CNC1=O)Cl)O |